Nakajima Masaru, Yamada Masafumi, Yamaguchi Koji, Sakiyama Yukio, Oda Atsushi, Nelson David L, Yawaka Yasutaka, Ariga Tadashi
Division of Oral Functional Science, Department of Dentistry for Children and Disabled Person, Hokkaido University Graduate School of Dental Medicine, Sapporo, Japan.
Eur J Haematol. 2009 Mar;82(3):223-30. doi: 10.1111/j.1600-0609.2008.01180.x. Epub 2008 Nov 5.
The Wiskott-Aldrich syndrome protein (WASP), which is defective in Wiskott-Aldrich syndrome (WAS) patients, is an intracellular protein expressed in non-erythroid hematopoietic cells. Previously, we have established methods to detect intracellular WASP expression in peripheral blood mononuclear cells (PBMNCs) using flow cytometric analysis (FCM-WASP) and have revealed that WAS patients showed absent or very low level intracellular WASP expression in lymphocytes and monocytes, while a significant amount of WASP was detected in those of normal individuals. We applied these methods for diagnostic screening of WAS patients and WAS carriers, as well as to the evaluation of mixed chimera in WAS patients who had previously undergone hematopoietic stem cell transplantation. During these procedures, we have noticed that lymphocytes from normal control individuals showed dual positive peaks, while their monocytes invariably showed a single sharp WASP-positive peak. To investigate the basis of the dual positive peaks (WASP(low-bright) and WASP(high-bright)), we characterized the constituent linage lymphocytes of these two WASP-positive populations. As a result, we found each WASP(low/high) population comprised different linage PBMNCs. Furthermore, we propose that the difference between the two WASP-positive peaks did not result from any difference in WASP expression in the cells, but rather from a difference in the structural and functional status of the WASP protein in the cells. It has been shown that WASP may exist in two forms; an activated or inactivated form. Thus, the structural and functional WASP status or configuration could be evaluated by flow cytometric analysis.
威斯科特-奥尔德里奇综合征蛋白(WASP)在威斯科特-奥尔德里奇综合征(WAS)患者中存在缺陷,是一种在非红细胞造血细胞中表达的细胞内蛋白。此前,我们已建立了利用流式细胞术分析(FCM-WASP)检测外周血单个核细胞(PBMNCs)中细胞内WASP表达的方法,并发现WAS患者淋巴细胞和单核细胞内WASP表达缺失或水平极低,而正常个体的这些细胞中可检测到大量WASP。我们将这些方法应用于WAS患者和WAS携带者的诊断筛查,以及评估先前接受过造血干细胞移植的WAS患者的混合嵌合体。在这些过程中,我们注意到正常对照个体的淋巴细胞呈现双阳性峰,而其单核细胞始终呈现单一尖锐的WASP阳性峰。为了探究双阳性峰(WASP(低亮度)和WASP(高亮度))的基础,我们对这两个WASP阳性群体的组成谱系淋巴细胞进行了表征。结果,我们发现每个WASP(低/高)群体由不同谱系的PBMNCs组成。此外,我们提出两个WASP阳性峰之间的差异并非源于细胞中WASP表达的任何差异,而是源于细胞中WASP蛋白的结构和功能状态的差异。已表明WASP可能以两种形式存在;一种激活形式或失活形式。因此,WASP的结构和功能状态或构象可通过流式细胞术分析进行评估。